首页|Antiophidic potential of chlorogenic acid and rosmarinic acid against Bothrops leucurus snake venom
Antiophidic potential of chlorogenic acid and rosmarinic acid against Bothrops leucurus snake venom
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Bothrops leucurus is responsible for most cases of snakebite in Northeast Brazil; however, this species is not included in the pool of venoms used in antivenom production in Brazil. The serotherapy has logistical and effectiveness limitations, which stimulates the search for therapeutic alternatives. Chlorogenic acid and rosmarinic acid present several biological activities, but their antiophidic potential has been poorly explored. Thus, the aim of this approach was to evaluate the potential inhibitory effects of these compounds on B. leucurus venom. Initially, the enzymatic inhibition of toxins was evaluated in vitro. Then, anti-hemorrhagic, anti-myo-toxic, and anti-edematogenic assays were performed in vivo, as well analysis of several biochemical markers and hemostatic parameters. In addition, the interaction of inhibitors with SVMP and PLA2 was investigated by docking analysis. Results revealed that compounds inhibited in vitro the enzymatic activities and venom-induced edema, with a decrease in both myeloperoxidase and interleukin quantification. The inhibitors also attenuated the hemorrhagic and myotoxic actions and mitigated changes in serum biochemical and hemostatic markers, as well as decreased lipid peroxidation in liver and kidney tissues. Docking analysis revealed attractive interactions of both inhibitors with the zinc-binding site of SVMP and, in the case of PLA_2, chlorogenic acid showed a similar inhibition mechanism to that described for rosmarinic acid. The results evidenced the antiophidic potential of both compounds, which showed higher efficiency than antivenom serum. Thus, both inhibitors are promising candidates for future adjuvants to be used to complement antivenom serotherapy.
Antiophidic activityPhenolic compoundsBothrops leucurusInhibition of toxins
Diana Pontes da Silva、Sarah de Sousa Ferreira、Manoela Torres-Rego、Allanny Alves Furtado、Fabiana de Oliveira Yamashita、Davi Serradella Vieira、Marcela Abbott Galvao Ururahy、Arnobio Antonio da Silva-Júnior、Karla Patrícia de Oliveira Luna、Matheus de Freitas Fernes-Pedrosa、Eduardo Augusto da Silva Diniz
展开 >
Laboratory of Technology and Pharmaceutical Biotechnology (Tecbiofar), College of Pharmacy, Federal
NSTL
